Study guide
14.2 Pressure Injuries: NPIAP Staging, DTPI & Prevention
Certified Wound Specialist Physician CWSP
Track your progress as you read
Finished sections get a check mark.
1 Introduction
About the CWSP Exam
2 Chapter 1: Integumentary Anatomy & Wound Healing Biology
1.1 Skin Anatomy, Microstructure & Epidermal-Dermal Barrier Function 1.2 Acute vs Chronic Wound Healing Phases & Cellular Kinetics 1.3 Extracellular Matrix Composition, Collagen Architecture & MMP Regulation
3 Chapter 2: Musculoskeletal & Neurologic Anatomy
2.1 Musculoskeletal Anatomy of the Leg & Foot 2.2 Neuroanatomy & Nerve Physiology for Wound Care
4 Chapter 3: Cell Signaling, Biofilm & Barriers to Healing
3.1 Growth Factors, Cytokines & Angiogenic Pathways 3.2 Biofilm Microbiology, Quorum Sensing & Phenotypic Resistance 3.3 Cellular Senescence, Hypoxia & Inflammatory Arrest 3.4 Metabolic, Steroid & Nutritional Impairments in Wound Healing
5 Chapter 4: Patient Evaluation & Vascular Diagnostics
4.1 Comprehensive Patient & Periwound Physical Examination 4.2 Noninvasive Macrovascular Hemodynamics: ABI, TBI & Segmental Pressures 4.3 Microvascular Perfusion Diagnostics: TcPO2, SPP & Near-Infrared Spectroscopy 4.4 Diagnostic Angiography, Duplex Ultrasonography & Angiosome Concepts
6 Chapter 5: Pain, Risk, Functional & Nutrition Assessment
5.1 Wound Pain Assessment 5.2 Risk Assessment Tools & Risk Stratification 5.3 Functional & Cognitive Assessment 5.4 Nutrition Screening & Assessment
7 Chapter 6: Imaging, Biopsy, Atypical Wounds & Neuropathy
6.1 Musculoskeletal Imaging for Osteomyelitis & Deep Space Infections 6.2 Diagnostic Tissue Biopsy, Culture Techniques & Quantitative Microbiology 6.3 Diagnostic Differential of Atypical & Malignant Ulcerations 6.4 Comprehensive Diabetic Peripheral Neuropathy & Biomechanical Assessment
8 Chapter 7: Wound Bed Preparation, Debridement, Dressings & Topical Agents
7.1 TIME Principle & Wound Bed Preparation Framework 7.2 Surgical, Sharp, Enzymatic, Autolytic & Biosurgical Debridement Modalities 7.3 Advanced Wound Dressings, Exudate Control & Moisture Balance 7.4 Topical Agents: Antiseptics, Antibiotics & Active Topicals
9 Chapter 8: Cellular & Tissue-Based Products, NPWT & Hyperbaric Oxygen
8.1 Cellular, Acellular & Matrix-Like Advanced Biologics (CTPs) 8.2 Negative Pressure Wound Therapy (NPWT) & Instillation Protocols 8.3 Hyperbaric Oxygen Therapy (HBOT): Mechanisms, Indications & Safety
10 Chapter 9: Biophysical Technologies: Electrical Stimulation & Ultrasound
9.1 Electrical Stimulation for Wound Healing 9.2 Therapeutic Ultrasound in Wound Care
11 Chapter 10: Revascularization, Antimicrobial Stewardship & Offloading
10.1 Revascularization for Limb Salvage 10.2 Systemic Antimicrobial Stewardship & Deep Infection Management 10.3 Mechanical Offloading, Pressure Redistribution & Total Contact Casting
12 Chapter 11: Surgical Closure & Healing Complications
11.1 Surgical Closure, Skin Grafts, Flaps & Amputation Levels 11.2 Managing Complications: Bleeding, Allergy, Adverse Events & Scarring
13 Chapter 12: Nutrition Therapy & Case Review
12.1 Nutrition Therapy for Wound Healing 12.2 Case Review: Synthesizing Data, Outliers & Prognosis
14 Chapter 13: Diabetic & Ischemic Lower-Extremity Wounds
13.1 Diabetic Foot Ulcers: Pathophysiology, Staging & Limb Salvage 13.2 Peripheral Arterial Disease & Ischemic Extremity Ulcerations 13.3 Mixed Arterial-Venous Disease & Complex Diagnostic Dilemmas
15 Chapter 14: Venous Disease, Pressure Injuries, Lymphedema & Edema
14.1 Venous Leg Ulcers, Chronic Venous Insufficiency & Compression 14.2 Pressure Injuries: NPIAP Staging, DTPI & Prevention 14.3 Lymphedema, Phlebolymphedema & Complete Decongestive Therapy 14.4 Edema: Systemic vs. Local Causes
16 Chapter 15: Inflammatory, Calcific, Medication-Induced & Dermatologic Wounds
15.1 Autoimmune & Inflammatory Ulcerations: Pyoderma Gangrenosum & Vasculitis 15.2 Calciphylaxis & Radiation Tissue Injury 15.3 Medication-Induced & Hematologic Atypical Wounds 15.4 Dermatologic Conditions That Cause or Complicate Wounds
17 Chapter 16: Traumatic Wounds, Burns & Frostbite
16.1 Traumatic Wounds: Lacerations, Bites, Degloving & Open Fractures 16.2 Thermal Burns & Frostbite
18 Chapter 17: Surgical, Infectious & Pediatric Wounds
17.1 Surgical Wounds, Surgical Site Infection & Dehiscence 17.2 Infectious Causes of Wounds: Necrotizing, Mycobacterial, Fungal & Other Infections 17.3 Pediatric Wound Care
19 Chapter 18: Reimbursement, Regulation & Documentation
18.1 CPT Coding, Modifiers & Documentation for Debridement and Biologics 18.2 Regulatory Compliance, CMS Quality Programs & Hospital-Acquired Conditions 18.3 Documentation, Legal Concepts & Confidentiality
20 Chapter 19: Ethics, Adherence, Epidemiology & Evidence-Based Practice
19.1 Clinical Ethics, Informed Consent & Palliative Wound Management 19.2 Patient Adherence & Psychosocial Care 19.3 Epidemiology of Chronic Wounds 19.4 Research Literacy, Evidence-Based Medicine & Quality Improvement
14.2 Pressure Injuries: NPIAP Staging, DTPI & Prevention
Key Takeaways Explain This Topic AI
Pressure injuries result from sustained interface pressures exceeding capillary closing pressure (12–32 mmHg) compounded by shear, originating at the bone-muscle interface ('inside-out' phenomenon) where metabolically active muscle undergoes ischemic necrosis within 2 hours.
NPIAP staging classifies lesions from Stage 1 through Stage 4, Unstageable, and DTPI; reverse staging is strictly prohibited because healing occurs via repair rather than regeneration, requiring documentation as a 'healing Stage 4 pressure injury.'
Stable, dry, intact heel eschar serves as the body's biological cover and must NOT be debrided unless fluctuance or erythema develops; medical device-related injuries follow NPIAP staging, whereas mucosal membrane injuries cannot be staged with NPIAP criteria.
The Braden Scale assesses 6 subscales (Sensory Perception, Moisture, Activity, Mobility, Nutrition, Friction/Shear) with total scores from 6 to 23; scores ≤18 trigger standardized clinical prevention protocols, and scores ≤12 denote high or very high risk.
Prevention bundles use a 30-degree lateral tilt rather than a full 90-degree side-lying position, keep the head of the bed at 30 degrees or less when possible, float the heels, and avoid ring or donut-shaped devices.
Last updated: September 2026
14.2 Pressure Injuries: NPIAP Staging, DTPI & Prevention
Core Clinical Principle: A pressure injury is localized damage to the skin and underlying soft tissue, usually over a bony prominence or related to a medical or other device. The injury occurs as a result of intense and/or prolonged pressure in combination with shear . Rather than superficial skin abrasions, severe pressure injuries characteristically originate deep within skeletal muscle at the bone-muscle interface—an 'inside-out' phenomenon driven by cellular deformation and microvascular strangulation.
Pressure injuries represent a major hospital-acquired complication and clinical quality metric. Mastery of pressure injury pathophysiology, exact staging per the National Pressure Injury Advisory Panel (NPIAP) guidelines, validated risk assessment scoring, and targeted support surface mechanics is mandatory for certified wound care specialists.
Pathogenesis: Capillary Closing Pressure, Shear & Deformation
The development of pressure injuries is governed by a triad of mechanical and biophysical forces:
1. Capillary Closing Pressure & The Reswick-Rogers Curve
Microvascular blood flow through capillary loops depends on the balance between intraluminal hydrostatic pressure and external interstitial pressure:
Under normal resting physiological conditions, capillary closing pressure ranges from 12 to 32 mmHg (averaging ~32 mmHg at the arterial capillary limb, ~20 mmHg at the midpoint, and ~12 mmHg at the post-capillary venule).
When external interface pressure exceeds 32 mmHg , capillary beds collapse completely, halting microvascular perfusion. The resulting anoxia arrests cellular aerobic metabolism, depletes intracellular adenosine triphosphate (ATP), produces lactic acidosis, and leads to cellular death.
The Reswick and Rogers Inverse Pressure-Time Threshold: Tissue breakdown is not solely a function of pressure magnitude; it is a function of pressure multiplied by duration . A very high interface pressure (e.g., 100–150 mmHg over the ischial tuberosities when sitting on a hard chair) produces irreversible tissue infarction within 1 to 2 hours . Conversely, lower sustained pressures (e.g., 35–45 mmHg over the sacrum on an unyielding hospital mattress) produce identical ischemic necrosis if sustained continuously for 4 to 6 hours without pressure relief.
2. Shear Stress vs. Pure Vertical Pressure
Pure Pressure: A perpendicular (compressive) force that compresses tissue columns directly downward against bone.
Shear Stress: A parallel or tangential force generated when adjacent tissue layers slide across one another. Clinical archetype: A patient whose head-of-bed (HOB) is elevated >30 degrees slides downward toward the foot of the bed. The outer epidermis and dermis remain fixed against the bed linens by friction, while the deep skeleton, fascia, and muscle glide downward under gravity.
Microvascular Angulation & Kinking: Shear stretches, angulates, and shears off the perforating microvessels that traverse the deep muscular fascia to supply the subcutaneous adipose and overlying skin. Shear forces reduce the external interface pressure required to produce complete microvascular occlusion by more than 50% .
3. Direct Mechanical Cell Deformation & The "Inside-Out" Phenomenon
Historically, pressure injuries were viewed purely as ischemic necrosis. Modern biomechanical research proves that direct, rapid mechanical cell deformation induces immediate structural disruption of cellular plasma membranes, cytoskeletal collapse, and activation of stretch-activated apoptotic pathways within minutes, well before ischemic injury matures.
Skeletal Muscle Vulnerability: Skeletal muscle has a substantially higher metabolic rate, denser vascularity, and greater sensitivity to mechanical compression than subcutaneous adipose tissue or dermis. Under sustained pressure over a bony prominence (e.g., sacrum, greater trochanter, ischial tuberosity), muscle necrosis occurs within 2 hours , whereas skin can withstand identical ischemia for up to 4 to 8 hours.
The Cone of Necrosis: Pressure distribution through tissue resembles an inverted cone with its apex at the skin surface and its wide base at the bone-muscle interface. Consequently, extensive, catastrophic necrosis may destroy deep muscle and fascia while the overlying skin displays only subtle, deceptively mild erythema or purplish discoloration. This explains why deep pressure injuries (Stage 3, 4, DTPI) appear to 'erupt' from within.
4. Ischemia-Reperfusion Injury (I-R Injury)
When a patient is turned after prolonged immobilization, restoring blood flow into previously ischemic tissue beds triggers a paradoxical second wave of cellular destruction. Re-oxygenation stimulates endothelial xanthine oxidase to flood tissues with toxic reactive oxygen species (ROS) (superoxide radicals, hydroxyl radicals, hydrogen peroxide). ROS induce extensive lipid peroxidation of cell membranes, massive neutrophil chemotaxis, and microvascular thrombosis, worsening tissue loss.
NPIAP 2019 Staging System for Pressure Injuries
The National Pressure Injury Advisory Panel (NPIAP) updated staging system provides definitive criteria for classifying soft-tissue damage: +-------------------------------------------------------------------------------------------------+
- | NPIAP PRESSURE INJURY STAGING FRAMEWORK |
- +-------------------------------------------------------------------------------------------------+
- | STAGE 1 : Non-blanchable erythema of intact skin |
- | STAGE 2 : Partial-thickness skin loss with exposed dermis (serum blister / pink moist bed) |
- | STAGE 3 : Full-thickness skin loss (adipose visible; granulation / epibole; slough/eschar) |
- | STAGE 4 : Full-thickness skin & tissue loss (exposed/palpable fascia, muscle, tendon, bone) |
- | UNSTAGEABLE : Full-thickness loss obscured by slough/eschar (Heel eschar = DO NOT DEBRIDE!) |
- | DTPI : Persistent non-blanchable deep red, maroon, or purple discoloration (bone-muscle origin) |
- +-------------------------------------------------------------------------------------------------+
- Detailed Staging Criteria & Board Distinctions
- Stage 1 Pressure Injury: Non-Blanchable Erythema of Intact Skin
Definition: Intact skin with a localized area of non-blanchable erythema , which may appear differently in darkly pigmented skin.
Clinical Signs: Upon applying light fingertip pressure, the redness does NOT whiten (blanch), confirming structural microvascular capillary damage and extravasation rather than transient reactive hyperemia.
Pigmentation Considerations: In darkly pigmented skin, erythema may be completely absent. The clinician must palpate for localized differences in temperature (warmth or cool firmness) , tissue induration/edema, and subtle dark purplish or ashen hues relative to surrounding healthy skin.
Board Distinction: Blanchable erythema is NOT a Stage 1 pressure injury! Blanchable erythema represents physiological reactive hyperemia (compensatory vasodilation) and is completely reversible within 20 to 30 minutes of pressure offloading.
Stage 2 Pressure Injury: Partial-Thickness Skin Loss with Exposed Dermis
Definition: Partial-thickness loss of skin with exposed dermis. The wound bed is viable, pink or red, moist, and free of slough.
Clinical Presentation: May also manifest as an intact or ruptured serum-filled blister . Adipose (subcutaneous fat) and deeper tissues are NOT visible .
Strict Negative Criteria: Granulation tissue, slough, and eschar are NEVER present in a Stage 2 pressure injury! If slough, necrotic eschar, or adipose is visible, the injury is at least Stage 3.
Differential Exclusion: Stage 2 should never be used to describe moisture-associated skin damage (MASD), incontinence-associated dermatitis (IAD), intertriginous dermatitis (ITD), medical adhesive-related skin injuries (MARSI), or skin tears.
Stage 3 Pressure Injury: Full-Thickness Skin Loss
Definition: Full-thickness loss of skin, in which adipose (fat) is visible in the ulcer , and granulation tissue and epibole (rolled wound edges) are often present.
Necrosis: Slough and/or eschar may be visible, but does NOT obscure the depth of tissue loss (if it completely obscures the base, it is Unstageable). Undermining and tunneling may occur.
Deeper Structures: Fascia, muscle, tendon, ligament, cartilage, and bone are NOT exposed or directly palpable .
Anatomical Depth Variation: In anatomical areas devoid of subcutaneous adipose tissue—such as the bridge of the nose, ear helix, occiput, and malleoli—Stage 3 ulcers can be extremely shallow (1 to 2 mm deep) , yet they remain true full-thickness Stage 3 injuries because the entire dermal thickness is lost down to underlying perichondrium or periosteum.
Stage 4 Pressure Injury: Full-Thickness Skin and Tissue Loss
Definition: Full-thickness skin and tissue loss with exposed or directly palpable fascia, muscle, tendon, ligament, cartilage, or bone .
Clinical Features: Slough and/or eschar may be visible. Epibole (rolled edges), extensive undermining, and deep sinus tracts/tunneling are frequently present.
Complications: High risk of underlying cortical erosion and osteomyelitis ; a positive probe-to-bone (PTB) test strongly correlates with histological bone infection.
Unstageable Pressure Injury: Obscured Full-Thickness Skin and Tissue Loss
Definition: Full-thickness skin and tissue loss in which the actual extent of tissue damage within the ulcer cannot be confirmed because it is obscured by slough or eschar .
Staging Rule: Once sufficient slough or eschar is debrided to expose the base of the wound bed, a Stage 3 or Stage 4 pressure injury will be revealed. (It is NEVER a Stage 1 or Stage 2 once unroofed, because eschar signifies full-thickness dermal necrosis).
THE LIFE-CRITICAL HEEL ESCHAR EXCEPTION: Stable (dry, adherent, intact without erythema, fluctuance, or drainage) eschar on the heel or ischemic limb serves as 'the body's natural (biological) cover' and MUST NOT BE DEBRIDED, MOISTENED, OR UNROOFED! NPIAP guidance states that stable eschar on an ischemic limb or the heel should not be removed. Keep it dry and protected (many clinicians paint it with povidone-iodine), float the heel completely, and assess perfusion. Debridement is indicated ONLY if the eschar becomes fluctuant, moist, boggy, malodorous, or develops surrounding cellulitis.
Deep Tissue Pressure Injury (DTPI): Persistent Non-Blanchable Discoloration
Definition: Intact or non-intact skin with localized, persistent non-blanchable deep red, maroon, or purple discoloration , or epidermal separation revealing a dark wound bed or blood-filled blister.
Mechanism: Caused by intense and/or prolonged pressure and shear forces occurring deep at the bone-muscle interface .
Clinical Evolution: Pain and temperature changes (localized cool or warm firmness) frequently precede discoloration. The wound may evolve rapidly to reveal the true extent of tissue injury (rapidly opening into an extensive Stage 3 or Stage 4 ulcer within 48–72 hours despite aggressive care), or it may resolve without significant tissue loss if pressure is eliminated immediately.
Medical Device-Related Pressure Injury (MDRPI) & Mucosal Membrane Pressure Injury
MDRPI: Results from the use of devices designed and applied for diagnostic or therapeutic purposes (e.g., endotracheal tubes, tracheostomy ties, CPAP masks, cervical collars, urinary catheters, pneumatic compression sleeves). The resulting injury typically matches the exact pattern or shape of the device. MDRPIs are staged using the standard NPIAP system.
Mucosal Membrane Pressure Injury: Occurs on mucous membranes subjected to medical device pressure (e.g., nasogastric tubes causing alar/nasal mucosal erosion, endotracheal tubes eroding lips/tongue, indwelling Foley catheters eroding the urethral meatus). Mucosal membrane pressure injuries CANNOT BE STAGED using the NPIAP system because mucosal tissues lack epidermis, dermis, and subcutaneous fat layers. PRACTICE POINT: THE PROHIBITION OF REVERSE STAGING
==================================================================================
Pressure injuries HEAL BY REPAIR (SCAR FORMATION), NOT HISTOLOGICAL REGENERATION!
- A Stage 4 pressure injury that has granulated up to dermal level DOES NOT become
- a Stage 3, Stage 2, or Stage 1. Lost muscle, fascia, and dermis do not regrow;
they are replaced by vascular granulation tissue and collagenous scar tissue.
Scar tissue achieves at most 80% of native tensile strength and lacks elastic fibers
and epidermal appendages, leaving the site permanently susceptible to re-breakdown.
--> CORRECT CLINICAL DOCUMENTATION: 'A healing Stage 4 pressure injury' or
'A closed/resolved Stage 4 pressure injury.' Never 'reverse-stage' backwards!
- ==================================================================================
- Pressure Injury Risk Assessment: The Braden Scale
The Braden Scale for Predicting Pressure Sore Risk is the most extensively validated clinical assessment tool in adult populations. It comprises 6 clinical subscales :
Subscale Description / Scoring Range Clinical Assessment Parameters
1. Sensory Perception Score 1 to 4 Ability to respond meaningfully to pressure-related discomfort.; • 1 = Completely Limited (unresponsive); • 2 = Very Limited (responds only to painful stimuli); • 3 = Slightly Limited (responds to verbal commands); • 4 = No Impairment
2. Moisture Score 1 to 4 Degree to which skin is exposed to moisture (sweat, urine, stool).; • 1 = Constantly Moist; • 2 = Very Moist (linens changed ≥1x/shift); • 3 = Occasionally Moist; • 4 = Rarely Moist
3. Activity Score 1 to 4 Degree of physical activity.; • 1 = Bedfast (confined to bed); • 2 = Chairfast (unable to bear weight); • 3 = Walks Occasionally; • 4 = Walks Frequently
4. Mobility Score 1 to 4 Ability to change and control body position independently.; • 1 = Completely Immobile (cannot make slight changes); • 2 = Very Limited (occasional slight shifts); • 3 = Slightly Limited (frequent minor shifts); • 4 = No Limitations
5. Nutrition Score 1 to 4 Usual food intake pattern.; • 1 = Very Poor (eats <1/3 meal; NPO >5 days); • 2 = Probably Inadequate (eats ~1/2 meal); • 3 = Adequate (eats >1/2 of most meals); • 4 = Excellent (eats most of every meal)
6. Friction & Shear Score 1 to 3 (Note: Max score is 3!) Mechanical sliding forces against support surfaces.; • 1 = Problem (requires moderate-to-maximum assist to move; slides down); • 2 = Potential Problem (moves feebly, occasional sliding); • 3 = No Apparent Problem (moves independently, maintains position)
Scoring Breakdown & Risk Stratification
Total Score Range: 6 to 23 (Lower score = Higher risk of pressure injury!).
Risk Thresholds:
Score 19 to 23: No risk / low baseline risk.
Score 15 to 18: Mild risk (triggers preventive nursing protocols).
Score 13 to 14: Moderate risk.
Score 10 to 12: High risk.
Score ≤ 9: Very high / severe risk.
The Universal Action Threshold: A total Braden score of ≤ 18 represents the internationally accepted clinical cutoff requiring immediate implementation of standardized multi-component pressure injury prevention interventions.
Support Surfaces & Pressure Redistribution Technology
Support surfaces are specialized medical devices (mattresses, overlays, cushions) designed to redistribute interface pressures, manage shear forces, and control the microclimate. SUPPORT SURFACE TAXONOMY & MECHANICAL PARADIGMS
==================================================================================
1. REACTIVE SUPPORT SURFACES (Non-Powered or Powered Constant Immersion):
• Operates by IMMERSION (depth of sinking into surface) and ENVELOPMENT (conformity
of surface around body contours), maximizing contact surface area (P = F / A).
• Examples: High-specification viscoelastic foam, static air-filled cells, gel cushions.
2. ACTIVE SUPPORT SURFACES (Powered Dynamic Redistribution):
• Mechanically changes contact pressure points beneath the body cyclically and
automatically, regardless of whether the patient moves.
• Example: Alternating-Pressure Air Mattresses (APAM; cyclic inflation/deflation).
3. INTEGRATED ADVANCED MATTRESSES (Microclimate & Fluidization):
• Low-Air-Loss (LAL): Circulates continuous warm air through vapor-permeable fabric,
wicking heat and moisture away from skin (controls maceration) + pressure redistribution.
• Air-Fluidized Therapy (AFT): High-volume warmed air pumped through microspheres
(silicone-coated glass beads), behaving as a buoyant liquid; lowest interface pressures.
- ==================================================================================
- Detailed Support Surface Mechanics
Surface Category Working Mechanism Pressure Profile Indications Board Contraindications / Caveats
High-Specification Viscoelastic Foam Open-cell memory foam with variable density contours. Non-powered reactive. Lowers peak interface pressure compared to standard hospital mattresses. Prevention in low-to-moderate risk (Braden 15–18); Stage 1 or 2 pressure injuries. Standard hospital foam mattresses (<4 inches thick) are NOT high-specification and do NOT provide adequate pressure relief!
Alternating-Pressure Air Mattress (APAM) Powered active dynamic surface. Alternating rows of pneumatic bladders inflate and deflate in a 10- to 20-minute cycle. Cyclically drops interface pressure to near 0 mmHg under deflated bladders, allowing microvascular reperfusion. Moderate-to-high risk patients (Braden ≤12); Stage 3 or 4 pressure injuries; immobile patients. May cause motion sickness or disorientation in agitated patients. Bladders must not bottom out.
Low-Air-Loss (LAL) Series of inflated air cells continuously expelling low-velocity air beneath a vapor-permeable coverlet. Dynamic reactive or active pressure redistribution + active microclimate management . Patients with excessive diaphoresis, wound drainage, or incontinence-induced skin maceration; multiple pressure injuries. Not equivalent to air-fluidized therapy; requires careful monitoring of transepidermal water loss.
Air-Fluidized Therapy (AFT) Warmed air pumped through 100 microns of silicone-coated ceramic/glass beads, creating a fluid-like state. Flotation/immersion: reduces interface pressure to <15 mmHg (well below capillary closing pressure of 32 mmHg). Severe refractory Stage 3/4 ulcers , extensive myocutaneous flap reconstructions, intractable bilateral trochanteric/ischial breakdown. Contraindications: Severe congestive heart failure / pulmonary edema (causes fluid mobilization into central circulation); unstable spinal fractures; ambulatory patients (cannot stand).
Repositioning, Patient Handling & Heel Offloading Protocols
Support surfaces reduce interface pressures but never eliminate the absolute requirement for scheduled physical repositioning .
1. The 2-Hour Bed Repositioning Schedule & The 30-Degree Lateral Tilt
Repositioning Frequency: Non-ambulatory patients confined to bed must be repositioned at least every 2 hours (or more frequently if skin tolerance is poor). On high-specification active surfaces, repositioning intervals may be adjusted based on clinical judgment, but should never exceed 2 to 4 hours.
The 30-Degree Lateral Tilt (The Oblique Position): When turning a patient onto their side, the patient must be placed in a 30-degree tilted lateral position supported by angled wedge pillows behind the back.
Critical Biomechanical Rationale: Placing a patient at a direct 90-degree lateral angle concentrates the entire weight of the torso directly onto the greater trochanter of the femur , where interface pressures are highest, increasing the risk of trochanteric injury. The 30-degree tilt redistributes weight onto the postero-lateral gluteal mass, offloading both the greater trochanter and the sacrum/coccyx.
Head-of-Bed (HOB) Elevation ≤ 30 Degrees: To prevent shear stress on the sacrum and coccyx, the HOB must be maintained at ≤ 30 degrees , except during active meals or pulmonary aspiration precautions.
Chair Repositioning: Teach seated patients to shift their weight frequently, and limit continuous sitting time for patients with existing pressure injuries on a sitting surface, using a pressure-redistributing cushion.
2. Heel Suspension & The Prohibition of Donut Devices
Heel Vulnerability: The calcaneus is the second most common site for pressure injuries (after the sacrum). It has minimal subcutaneous fat padding, no muscular cushioning, and the overlying skin is tethered directly to the calcaneal periosteum.
Heel Offloading Mandate: High-risk heels must be completely suspended ('floated') off the support surface so that zero interface pressure is exerted on the calcaneus. This is achieved using heel suspension boots (e.g., Prevalon, Heelift) or by placing a pillow lengthwise under the calves to elevate the Achilles tendon and elevate the heels entirely in the air.
The Donut / Ring Device Prohibition: The international pressure injury guideline recommends avoiding ring or donut-shaped devices . A donut device exerts intense circumferential constrictive pressure on the venous microvasculature surrounding the central defect, creating severe venous congestion, localized edema, and downstream microvascular ischemia that accelerates tissue necrosis.